| Description | Pegcantratinib is a tropomyosin receptor kinase inhibitor for treatment for inherited CYLD defective skin tumours. |
| molecular weight | 580.59 |
| Molecular formula | C32H28N4O7 |
| CAS | 1233363-33-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |